tiprankstipranks
Regeneron (REGN)
NASDAQ:REGN

Regeneron (REGN) Stock News & Sentiment

3,989 Followers
Kevzara® (sarilumab) Approved by FDA for the Treatment of Active Polyarticular Juvenile Idiopathic Arthritis (pJIA)
PremiumPress Releases
Kevzara® (sarilumab) Approved by FDA for the Treatment of Active Polyarticular Juvenile Idiopathic Arthritis (pJIA)
1d ago
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD
PremiumPress Releases
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD
12d ago
Update on FDA Priority Review of Dupixent® (dupilumab) for the Treatment of COPD Patients with Type 2 Inflammation
PremiumPress Releases
Update on FDA Priority Review of Dupixent® (dupilumab) for the Treatment of COPD Patients with Type 2 Inflammation
12d ago
Promising Anti-tumor Activity of Novel Costimulatory Bispecific Antibody REGN7075 (EGFRxCD28) in Combination with Libtayo® (cemiplimab) to be Reported at ASCO
PremiumPress Releases
Promising Anti-tumor Activity of Novel Costimulatory Bispecific Antibody REGN7075 (EGFRxCD28) in Combination with Libtayo® (cemiplimab) to be Reported at ASCO
20d ago
Dupixent® (dupilumab) Late-Breaking Data from NOTUS Confirmatory Phase 3 COPD Trial Presented at ATS and Published in The New England Journal of Medicine
PremiumPress Releases
Dupixent® (dupilumab) Late-Breaking Data from NOTUS Confirmatory Phase 3 COPD Trial Presented at ATS and Published in The New England Journal of Medicine
23d ago
More than $9 Million Awarded to High School Scientists and Engineers at the Regeneron International Science and Engineering Fair 2024
PremiumPress Releases
More than $9 Million Awarded to High School Scientists and Engineers at the Regeneron International Science and Engineering Fair 2024
26d ago
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP)
PremiumPress Releases
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP)
1M ago
More REGN News >

News Score - Last 7 Days

Neutral
REGN
Sector Average
Media Buzz
This Week7 articles
Weekly Average9.75 articles
News Sentiment
This Week50%
Sector Average60%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is REGN’s Media Buzz Sentiment?
7 articles about REGN were published this week. In an average week, 9.75 articles are published.
    What is REGN’s weekly average amount of articles?
    In an average week, 9.75 articles about REGN are published.
      What is REGN’s News Sentiment?
      50% of articles about REGN were positive this week, compared to its sector average of 60%.
        Healthcare Stocks that are Trending in the News
        GERNGeron
        VRDNViridian Therapeutics
        BMEABiomea Fusion
        TYRATyra Bioscience
        HALOHalozyme
        Showing the stocks with the most bullish news sentiment over the past week
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis